12月8日晚间，京基智农连续披露包括股份回购计划、控股股东提前结束减持、高管承诺不减持等在内 的多份公告，推出一系列回馈股东、稳定市场的组合拳，以实际行动履行对投资者的责任与承诺。 京基智农表示，基于对自身未来发展前景的信心，同时为进一步健全公司长效激励机制，在综合考量公 司经营情况、财务状况及近期公司股票二级市场表现等因素的基础上，公司拟推出新一轮股份回购计 划。 本次回购资金总额为不低于人民币1亿元且不超过人民币2亿元，回购期限为自董事会审议通过本次回购 股份方案之日起不超过6个月，按回购价格上限23.70元/股测算，最终回购股份的数量预计不低于421.94 万股，占公司总股本的比例不低于0.80%。本次回购的股份将用于实施股权激励或员工持股计划。 针对近期市场广泛关注的股东减持问题，公司控股股东及高管也作出了积极回应。京基智农控股股东京 基集团发布通知，决定提前终止此前于10月28日披露的股份减持计划。与此同时，京基智农6位董事、 高级管理人员共同签署承诺函，承诺自2025年12月8日起6个月内不以任何方式减持其持有的公司股份。 分析人士指出，上述举措彰显了控股股东及高管对京基智农内在价值的长期看好，以 ...

Core Viewpoint - TianKang Biological (002100) has successfully reduced its breeding costs in the Gansu region to 12.25 yuan/kg as of September, attributed to enhanced management, technology, and production efforts over the past two years [1] Group 1: Cost Reduction - The cost in the Gansu region has decreased to 12.25 yuan/kg as of September [1] - The company has focused on improving management and technical capabilities in Gansu, which was previously lagging in breeding and management standards [1] Group 2: Management Innovations - The company has implemented an internal contracting system that links breeding results to the income of breeders and management personnel, thereby increasing their sense of responsibility [1] - Key personnel have been transferred from Xinjiang and Henan to strengthen the regional team, leading to significant improvements in breeding standards [1]